Abstract
An important step m the development of modern experimental virology was the development of the plaque assay, first with bacteriophage, then with eukaryotic viruses. In order to obtain quantitative, interpretable, and reproducible results, it is necessary to know how much virus is being used in the experiment. With adenoviruses, several approaches have generally been used to quantitate virus stocks. First, virus particles are counted, e.g., in an electron microscope (1,2). Another approach is to quantitate virion DNA by optical absorbance (2). The problem with these approaches is that many adenovirus particles are not infectious, perhaps because they have a defective complete genome or they lack fiber or some other protein. The second approach is to determine the number of plaque-forming units (PFU) per mL. Here, the analysis quantitates the number of virions capable of a full infectious cycle. This approach will be described in detail in this article.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Pinteric, L. and Taylor, J. (1962) The lowered drop method for the preparation of specimens of partially purified virus lysates for quantitative electron micrographic analysis. virology l8, 359–371.
Mittereder, N., March, K. L., and Trapnell, B. C (1996) Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J Virol. 70, 7498–750
Green, M. and Pina, M. (1963) Biochemical studies on adenovirus multiplication. IV. Isolation, purification, and chemical analysis of adenovirus. Virology 20, 199–207.
Green, M. and Wold, W. S. M. (1979) Human adenoviruses: growth, purification, and transfection assay. Methods Enzymol. 58, 425–435.
Hashimoto, S., Sakakibara, N., Kumai, H., Nakai, M., Sakuma, S., Chiba, S., and Fujinaga, K. (1991) Fastidious human adenovirus type 40 can propagate efficiently and produce plaques on a human cell line, A549, derived from lung carcinoma. J Virol. 65, 2429–2435.
Green, M., Pina, M., and Kimes, R. C. (1967) Biochemical studies on adenovirus multiplication. XII. Plaquing efficiencies of purified human adenoviruses. Discussion and preliminary reports. Virology 31, 562–565.
Tollefson, A. E., Scaria, A., Hermiston, T. W., Ryerse, J. S., Wold, L. J., and Wold, W. S. M. (1996) The adenovirus death protein (E3-11.6K) is required at very late stages of infection for efficient cell lysis and release of adenovirus from infected cells. J. Viral. 70, 2296–2308
Tollefson, A. E., Ryerse, J. S., Scaria, A., Hermiston, T. W., and Wold, W. S. M. (1996) The E3-11.6kDa adenovirus death protein (ADP) is required for efficient cell death: characterization of cells Infected with adp mutants. Virology 220, 152–162.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Tollefson, A.E., Hermiston, T.W., Wold, W.S.M. (1999). Preparation and Titration of CsCl-Banded Adenovirus Stock. In: Wold, W.S.M. (eds) Adenovirus Methods and Protocols. Methods in Molecular Medicine™, vol 21. Springer, Totowa, NJ. https://doi.org/10.1385/0-89603-551-4:1
Download citation
DOI: https://doi.org/10.1385/0-89603-551-4:1
Publisher Name: Springer, Totowa, NJ
Print ISBN: 978-0-89603-551-5
Online ISBN: 978-1-59259-603-4
eBook Packages: Springer Protocols